These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1398412)

  • 21. Effect of gemfibrozil on erythrocyte membrane lipids in geriatric patients.
    Bauer M; Platt D; Hager K
    Exp Gerontol; 1990; 25(1):37-46. PubMed ID: 2318281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol and prostate cancer.
    Harv Mens Health Watch; 2011 Jun; 15(11):6-7. PubMed ID: 21706781
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular mechanisms of lipid disorders in nephrotic syndrome.
    Vaziri ND
    Kidney Int; 2003 May; 63(5):1964-76. PubMed ID: 12675893
    [No Abstract]   [Full Text] [Related]  

  • 24. Cholesterol and chloroquine.
    Borba EF
    Rev Bras Reumatol; 2011 Dec; 51(6):673. PubMed ID: 22124601
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of combined pravastatin-gemfibrozil therapy.
    Rosenson RS; Frauenheim WA
    Am J Cardiol; 1994 Sep; 74(5):499-500. PubMed ID: 8059735
    [No Abstract]   [Full Text] [Related]  

  • 26. [Metabolism of magnesium and lipid disturbances in chronic renal failure].
    Fijałkowska-Morawska J; Chrzanowski W
    Pol Arch Med Wewn; 1997 Oct; 98(10):327-31. PubMed ID: 9557087
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of HDL cholesterol.
    Grubits J
    J R Soc Med; 1992 Aug; 85(8):509. PubMed ID: 1404215
    [No Abstract]   [Full Text] [Related]  

  • 28. Medication compliance and serum lipid changes in the Helsinki Heart Study.
    Mäenpää H; Heinonen OP; Manninen V
    Br J Clin Pharmacol; 1991 Oct; 32(4):409-15. PubMed ID: 1958432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response.
    Bosomworth J
    Can Fam Physician; 2014 Jan; 60(1):40. PubMed ID: 24600752
    [No Abstract]   [Full Text] [Related]  

  • 30. Lower treatment thresholds.
    Torontour S
    Can Fam Physician; 2014 Jan; 60(1):39-40. PubMed ID: 24452557
    [No Abstract]   [Full Text] [Related]  

  • 31. An interaction between Gemfibrozil and alpha 1-antitrypsin.
    Janciauskiene S; Eriksson S
    J Intern Med; 1994 Sep; 236(3):357-60. PubMed ID: 8077896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress and challenges in translating the biology of atherosclerosis.
    Libby P; Ridker PM; Hansson GK
    Nature; 2011 May; 473(7347):317-25. PubMed ID: 21593864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disorder in lipid metabolism].
    Motoyama A; Saito R; Fujibayashi K; Aoki H; Kajinami K
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():364-9. PubMed ID: 20976910
    [No Abstract]   [Full Text] [Related]  

  • 34. Further evidence of favorable effects of gemfibrozil on the lipid profile in renal allograft recipients.
    Ok E; Kursat S; Alev M; Tobu M; Tokat Y; Akcicek F; Hoscoskun C; Basci A
    Nephron; 1996; 73(3):491-2. PubMed ID: 8832618
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic effects of hormone replacement preparations.
    Sattar N; Packard CJ; Jaap AJ
    BMJ; 1996 Jun; 312(7046):1608. PubMed ID: 8664689
    [No Abstract]   [Full Text] [Related]  

  • 36. Rethinking cholesterol management. Lowering LDL levels is once again the Holy Grail, since raising HDL failed to make a difference after all.
    Duke Med Health News; 2013 Mar; 19(3):3. PubMed ID: 27024483
    [No Abstract]   [Full Text] [Related]  

  • 37. ANGPTL3 targeting: The power of versatile lipid-lowering.
    Pessentheiner AR; Ramms B; Gordts PLSM
    Atherosclerosis; 2018 Jan; 268():185-187. PubMed ID: 29111225
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gemfibrozil in the differential therapy of disorders of fat metabolism].
    Ebner F
    Fortschr Med; 1992 Oct; 110(28):523-6. PubMed ID: 1398412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels.
    Weis S; Kudchodkar BJ; Clearfield MB; Lacko AG
    Artery; 1992; 19(6):353-66. PubMed ID: 1471924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.